Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P33763 (
N-acetylmuramoyl-l-alanine amidase
)
28
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Peptidoglycan recognition proteins (PGRPs) are pattern recognition molecules coded by up to 13 genes in insects and 4 genes in mammals. In insects PGRPs activate antimicrobial pathways in the hemolymph and cells, or are peptidoglycan (PGN)-lytic amidases. In mammals one PGRP is an antibacterial neutrophil protein. We report that human
PGRP-L
is a Zn2+-dependent
N-acetylmuramoyl-l-alanine amidase
(EC 3.5.1.28), an enzyme that hydrolyzes the amide bond between MurNAc and l-Ala of bacterial PGN. The minimum PGN fragment hydrolyzed by
PGRP-L
is MurNAc-tripeptide.
PGRP-L
has no direct bacteriolytic activity. The other members of the human PGRP family, PGRP-Ialpha, PGRP-Ibeta, and PGRP-S, do not have the amidase activity. The C-terminal region of
PGRP-L
, homologous to bacteriophage and bacterial amidases, is required and sufficient for the amidase activity of
PGRP-L
, although its activity (in the N-terminal delta1-343 deletion mutant) is reduced. The Zn2+ binding amino acids (conserved in
PGRP-L
and T7 amidase) and Cys-419 (not conserved in T7 amidase) are required for the amidase activity of
PGRP-L
, whereas three other amino acids, needed for the activity of T7 amidase, are not required for the activity of
PGRP-L
. These amino acids, although required, are not sufficient for the amidase activity, because changing them to the "active" configuration does not convert PGRP-S into an active amidase. In conclusion, human
PGRP-L
is an
N-acetylmuramoyl-l-alanine amidase
and this function is conserved in prokaryotes, insects, and mammals.
...
PMID:Human peptidoglycan recognition protein-L is an N-acetylmuramoyl-L-alanine amidase. 1450 76